Skip to content

Study to Assess Participant Satisfaction After Jawline and Neck Treatment

A Prospective, Open-label Study to Evaluate Subject Satisfaction and Psychosocial Outcomes After Treatment of Jawline and Neck With BOTOX® Cosmetic and JUVÉDERM® Products

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07794891
Enrollment
100
Registered
2026-08-31
Start date
2026-09-04
Completion date
2027-06-01
Last updated
2026-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Jawline and Neck Appearance

Keywords

AURA Study, Jaw area and Neck Appearance, onabotulinumtoxinA, JUVÉDERM

Brief summary

The goal of this study is to evaluate overall participant satisfaction with the jawline and neck. Participants will receive select Juvéderm products and onabotulinumtoxinA in the jaw area and neck per eligibility criteria. The study will measure changes in psychological function, satisfaction with lower face and jawline and skin appearance. Participants will attend visits during the study at a clinical site. The effects of the treatment will be checked by medical assessments, vital signs, physical examinations, checking for side effects, and completing questionnaires.

Interventions

DRUGOnabotulinumtoxinA

Injection

DEVICESKINVIVE

Injection

DEVICEVOLUX

Injection

DEVICEVOLUMA

Injection

Sponsors

AbbVie
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
22 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Moderate or severe transverse neck lines based on investigator's live assessment * Moderate or severe loss of jawline definition based on investigator's live assessment. * Moderate or severe platysma prominence based on investigator's live assessment.

Exclusion criteria

* History of or current medical condition that may put the subject at increased medical risk with exposure to BOTOX, or any other condition that might interfere with neuromuscular function. * History of or current symptoms of dysphagia. * History of severe allergies manifested by a history of anaphylaxis or history or presence of multiple severe allergies. * History of hypersensitivity or allergy to any botulinum toxin serotype, Streptococcal or gram-positive bacterial proteins, lidocaine, HA products, any other excipients or constituents of the study drug, device, and/or other products in the same class. * History of or tendency for keloid formation, hyperpigmentation, or hypertrophic scarring.

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Participants With Response of Satisfied or Very Satisfied on Appearance of Neck and Lower Face Questionnaire (ANLFQ): Satisfaction Follow-UpDay 104The ANLFQ is a 5-point scale that assesses participant satisfaction. Response options range from Very satisfied to Very dissatisfied.

Secondary

MeasureTime frameDescription
Change From Baseline in Participant's Rasch-transformed Score of the FACE-Q Psychological FunctionUp to approximately 104 daysThe FACE-Q Psychological Function scale assesses the psychological impact of facial appearance. The Rasch-transformed summary score ranges from worst to best.
Change From Baseline in Participant's Rasch-transformed Score of the FACE-Q Satisfaction With Lower Face and JawlineUp to approximately 104 daysFACE-Q Satisfaction assesses participant satisfaction with the appearance of their lower face and jawline. The Rasch-transformed summary score ranges from worst to best.
Change From Baseline in Participant's Rasch-transformed Score of the SKIN-Q - Skin LooksUp to approximately 104 daysSKIN-Q - Skin Looks assesses participant's satisfaction with how their skin looks. Rasch transformed scores ranges from worst to best.
Change From Baseline in Participant's Allergan Facial Confidence Scale (AFCS) - Confidence (Treatment Area) Total ScoreUp to approximately 104 daysAFCS - Confidence (Treatment Area) is a questionnaire that assesses the participant's confidence in the appearance of the treatment area. 4-point response option ranges from Very Confident to Not at all confident.
Percentage of Participants With Response of Improved or Much Improved on Investigator Global Aesthetic Improvement Scale (GAIS)Up to approximately 104 daysGAIS is a clinician-rated 5-point scale that assesses of overall aesthetic improvement compared to baseline. Scores range from "Much improved" to "Much worse".
Percentage of Participants With Response of Satisfied or Very Satisfied (or Agree or Definitely Agree) on Allergan Facial Satisfaction Scale (AFSS) - Natural Look and FeelUp to approximately 104 daysAFSS assesses participant satisfaction. Scores range from "Very satisfied" to" Very dissatisfied".

Contacts

CONTACTABBVIE CALL CENTER
abbvieclinicaltrials@abbvie.com844-663-3742
STUDY_DIRECTORABBVIE INC.

AbbVie

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 1, 2026